• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性淋巴细胞白血病患儿诱导治疗期间促凝血小板细胞外囊泡和 P-选择素增加的初步研究:两个新的血栓形成风险生物标志物?

A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?

机构信息

Department of Paediatric Oncology/Hematology, CHU de Reims, Reims, France.

EA3801-HERVI, Université de Reims Champagne-Ardenne, Reims, France.

出版信息

J Thromb Thrombolysis. 2021 Apr;51(3):711-719. doi: 10.1007/s11239-020-02346-7. Epub 2020 Nov 28.

DOI:10.1007/s11239-020-02346-7
PMID:33247807
Abstract

In paediatric acute lymphoblastic leukaemia (ALL), focus has shifted towards preventing treatment-related complications, including venous thromboembolism, the cause of significant mortality and morbidity. To better understand thrombogenic mechanisms during induction treatment, we studied the number, origin and procoagulant activity of extracellular vesicles (EVs) and P-selectin level throughout the induction course in 24 paediatric patients. EVs were mainly of platelet origin. We observed a significant increase in EV number, in platelet EV number and P-selectin level throughout the induction course. There was a correlation between higher EV and platelet EV number, P-selectin level, higher platelet count and leucocyte count. We also observed a correlation between higher EV procoagulant activity and higher platelet count and leucocyte count and higher P-selectin level. Older age and T phenotype were associated with a higher EV procoagulant activity. Platelet EV generation may play a role in thrombogenic complications in ALL patients and could serve as a biomarker to identify patients with a high risk of thrombosis. As a marker of platelet activation, P-selectin may be another relevant marker with the advantage of being easier to analyse in clinical practice.

摘要

在儿科急性淋巴细胞白血病 (ALL) 中,重点已转向预防治疗相关并发症,包括静脉血栓栓塞症,这是导致高死亡率和高发病率的原因。为了更好地了解诱导治疗期间的血栓形成机制,我们研究了 24 名儿科患者诱导治疗过程中细胞外囊泡 (EVs) 的数量、来源和促凝活性以及 P-选择素水平。EVs 主要来源于血小板。我们观察到 EV 数量、血小板 EV 数量和 P-选择素水平在整个诱导过程中显著增加。EV 数量和血小板 EV 数量、P-选择素水平、血小板计数和白细胞计数较高之间存在相关性。我们还观察到 EV 促凝活性与血小板计数和白细胞计数较高以及 P-选择素水平较高之间存在相关性。年龄较大和 T 表型与 EV 促凝活性较高有关。血小板 EV 的产生可能在 ALL 患者的血栓形成并发症中起作用,并可作为一种生物标志物,以识别具有高血栓形成风险的患者。作为血小板活化的标志物,P-选择素可能是另一个相关的标志物,其优势在于在临床实践中更容易分析。

相似文献

1
A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?急性淋巴细胞白血病患儿诱导治疗期间促凝血小板细胞外囊泡和 P-选择素增加的初步研究:两个新的血栓形成风险生物标志物?
J Thromb Thrombolysis. 2021 Apr;51(3):711-719. doi: 10.1007/s11239-020-02346-7. Epub 2020 Nov 28.
2
Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.细胞外囊泡的促凝血活性作为急性白血病患者血栓形成和弥散性血管内凝血风险的潜在生物标志物。
J Thromb Thrombolysis. 2017 Feb;43(2):224-232. doi: 10.1007/s11239-016-1471-z.
3
Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.随机对照试验方案,旨在研究急性心肌梗死中外周细胞外囊泡(AFFECT EV)的抗血小板治疗效果。
Platelets. 2020;31(1):26-32. doi: 10.1080/09537104.2018.1557616. Epub 2018 Dec 26.
4
Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.长春新碱通过释放细胞外囊泡诱导人急性淋巴细胞白血病细胞系 Jurkat 的促凝活性。
J Thromb Thrombolysis. 2019 Aug;48(2):195-202. doi: 10.1007/s11239-019-01894-x.
5
Successful renal denervation decreases the platelet activation status in hypertensive patients.成功的肾去神经支配可降低高血压患者的血小板激活状态。
Cardiovasc Res. 2020 Jan 1;116(1):202-210. doi: 10.1093/cvr/cvz033.
6
Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.抗血小板治疗对健康人群及心血管疾病患者血小板细胞外囊泡释放和促凝血活性的影响。
Platelets. 2016 Dec;27(8):805-811. doi: 10.1080/09537104.2016.1190008. Epub 2016 Jun 16.
7
Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis.癌症患者血小板反应性降低与静脉血栓栓塞的高风险和不良预后相关。
Thromb Haemost. 2017 Jan 5;117(1):90-98. doi: 10.1160/TH16-02-0123. Epub 2016 Oct 20.
8
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).癌症患者中血小板计数升高与静脉血栓栓塞相关:来自维也纳癌症与血栓研究(CATS)的结果。
J Thromb Haemost. 2010 Jan;8(1):114-20. doi: 10.1111/j.1538-7836.2009.03680.x. Epub 2009 Nov 2.
9
Platelet Activation via Shear Stress Exposure Induces a Differing Pattern of Biomarkers of Activation versus Biochemical Agonists.剪切应力量激活血小板会引起激活生物标志物与生化激动剂的不同模式。
Thromb Haemost. 2020 May;120(5):776-792. doi: 10.1055/s-0040-1709524. Epub 2020 May 5.
10
Procoagulant Effects of Low-Level Platelet Activation and Its Inhibition by Colchicine.秋水仙碱对低水平血小板激活的促凝作用及其抑制作用。
Thromb Haemost. 2018 Apr;118(4):723-733. doi: 10.1055/s-0038-1636915. Epub 2018 Mar 19.

引用本文的文献

1
Circulating Extracellular Vesicles Are Strongly Associated With Cardiovascular Risk Markers.循环细胞外囊泡与心血管风险标志物密切相关。
Front Cardiovasc Med. 2022 May 26;9:907457. doi: 10.3389/fcvm.2022.907457. eCollection 2022.

本文引用的文献

1
Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience.霍纳纳评分在急性髓系白血病患者中的验证:单机构经验
Thromb J. 2019 Jul 2;17:13. doi: 10.1186/s12959-019-0202-z. eCollection 2019.
2
Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.长春新碱通过释放细胞外囊泡诱导人急性淋巴细胞白血病细胞系 Jurkat 的促凝活性。
J Thromb Thrombolysis. 2019 Aug;48(2):195-202. doi: 10.1007/s11239-019-01894-x.
3
THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.
血栓预防研究 - 一项比较低分子肝素、抗凝血酶和未分级肝素在儿童和青少年急性淋巴细胞白血病诱导治疗期间预防血栓形成的随机研究。
Haematologica. 2019 Apr;104(4):756-765. doi: 10.3324/haematol.2018.194175. Epub 2018 Sep 27.
4
Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris.凋亡细胞衍生的细胞外囊泡:不止是碎片。
Front Immunol. 2018 Jun 28;9:1486. doi: 10.3389/fimmu.2018.01486. eCollection 2018.
5
Thrombosis in pediatric patients with leukemia.儿童白血病患者的血栓形成。
Thromb Res. 2018 Apr;164 Suppl 1:S94-S97. doi: 10.1016/j.thromres.2018.01.019.
6
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.急性淋巴细胞白血病中的血栓栓塞:NOPHO ALL2008 方案治疗 1 至 45 岁患者的结果。
Blood. 2018 May 31;131(22):2475-2484. doi: 10.1182/blood-2018-01-827949. Epub 2018 Apr 16.
7
Role of P-selectin in thromboembolic events in patients with cancer.P-选择素在癌症患者血栓栓塞事件中的作用。
Mol Clin Oncol. 2018 Jan;8(1):188-196. doi: 10.3892/mco.2017.1482. Epub 2017 Nov 2.
8
Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).儿童急性淋巴细胞白血病治疗中的危机处理:纠正可能出现的错误(疾病的紧急并发症和治疗)。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):251-258. doi: 10.1182/asheducation-2017.1.251.
9
Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.携带组织因子的微粒与炎症:癌症患者静脉血栓栓塞形成的潜在机制。
J Thromb Haemost. 2017 Dec;15(12):2289-2299. doi: 10.1111/jth.13871. Epub 2017 Nov 8.
10
Cancer-associated pathways and biomarkers of venous thrombosis.癌症相关的静脉血栓形成途径和生物标志物。
Blood. 2017 Sep 28;130(13):1499-1506. doi: 10.1182/blood-2017-03-743211. Epub 2017 Aug 14.